Larazotide Dosing Calculator
Larazotide acetate: zonulin receptor antagonist for celiac disease.
Pre-filled with the most-reported clinical reconstitution protocol for Larazotide. See how 1 mL and 2 mL of bacteriostatic water change concentration and syringe-draw volume, then adjust the calculator below for your own vial.
Quick answer · Clinical protocol
A 5 mg vial of Larazotide reconstituted with 2 mL of bacteriostatic water yields a concentration of 2.50 mg/mL. At that concentration, a 500 mcg dose of Larazotide equals 20 units on a U-100 insulin syringe (0.200 mL). Larazotide is typically administered once daily.
Larazotide reconstitution: 1 mL vs 2 mL bac water
Bacteriostatic water volume is flexible. Less water means higher concentration and smaller injection volumes; more water means lower concentration and easier dose precision. Both options below are valid for a 5 mg vial.
| BAC water added | Concentration | Volume per 500 mcg dose | Draw on U-100 syringe (units) |
|---|---|---|---|
| 1 mL | 5.00 mg/mL | 0.100 mL | 10 units |
| 2 mL | 2.50 mg/mL | 0.200 mL | 20 units |
Calculate your Larazotide dose
Alternative Larazotide protocols
Beyond the default above, Larazotide is also reported in the following protocols. Use these as starting points and recalculate with the tool above.
Standard Gut Permeability Protocol
Community- Dose
- 0.5 mg
- Frequency
- Three times daily (before meals)
- Duration
- 8-12 weeks
- Route
- Oral
Mirrors the Phase 2b clinical trial dose that showed statistical significance; taken 15 minutes before meals
Low-Dose Maintenance Protocol
Community- Dose
- 0.25 mg
- Frequency
- Three times daily
- Duration
- Ongoing
- Route
- Oral
Lower dose for ongoing gut permeability support; used by those with celiac disease on gluten-free diets
Leaky Gut Protocol
Community- Dose
- 0.5-1 mg
- Frequency
- Three times daily
- Duration
- 4-8 weeks
- Route
- Oral
Used beyond celiac disease for general intestinal permeability concerns; community extension of clinical indications
Celiac Disease (Phase 3 CeDLara)
Clinical- Dose
- 0.25 mg and 0.5 mg oral capsules three times daily in patients on a gluten-free diet with persistent symptoms.
- Frequency
- Three times daily
- Duration
- 24-week treatment period
Phase 3 trial was discontinued after interim analysis of 525 patients showed insufficient treatment effect to justify continuation.
Larazotide reconstitution & storage
Larazotide acetate is administered as oral capsules. No reconstitution, mixing, or injection preparation is required.
Clinical trial formulation stored under standard pharmaceutical conditions. Commercial storage guidelines not established as the product is not approved.
Larazotide dosing FAQ
How much bacteriostatic water should I add to a 5 mg vial of Larazotide?
The community standard is 2 mL of bacteriostatic water for a 5 mg Larazotide vial. That gives a concentration of 2.50 mg/mL, so a 500 mcg dose is 20 units on a U-100 insulin syringe. Adding 1 mL instead doubles the concentration to 5.00 mg/mL and halves the draw to 10 units. Less water = smaller injection volume but harder to measure precisely.
How many syringe units is a 500 mcg dose of Larazotide?
On a standard U-100 insulin syringe, a 500 mcg dose of Larazotide is 20 units when the 5 mg vial is reconstituted with 2 mL of bacteriostatic water (2.50 mg/mL). If you use 1 mL of bac water instead, draw 10 units (5.00 mg/mL).
What is the standard Larazotide dose?
Clinical protocols for Larazotide typically use 0.5 mgâ1 mg once daily via subcutaneous injection. 500 mcg is a common starting dose. The 0.5 mg TID dose was the only dose to reach statistical significance versus placebo. The inverted dose-response (lower dose more effective) may reflect receptor occupancy dynamics at the gut surface.
How long does a vial of Larazotide last at 500 mcg once daily?
A 5 mg vial of Larazotide contains roughly 10 doses at 500 mcg per injection. At once daily dosing, that is approximately 10 days (about 1 weeks) of supply per vial. Reconstituted Larazotide should generally be used within 28 days when refrigerated.
Where do you inject Larazotide?
Larazotide is typically injected subcutaneously. Common sites reported in the literature and by users include: Not applicable -- larazotide is an oral capsule formulation. Rotate sites with each injection to reduce localized irritation.
Can I use sterile water instead of bacteriostatic water for Larazotide?
Bacteriostatic water (containing 0.9% benzyl alcohol as a preservative) is strongly preferred for multi-dose vials like Larazotide because it inhibits microbial growth and lets a single vial be used over multiple weeks. Sterile water has no preservative and should generally be reserved for single-use preparations only.
More on Larazotide
Larazotide overview
Mechanism of action, primary uses, and research summary
Larazotide dosing protocols
Full clinical and research-based dosing reference
Larazotide community protocols
Real-world usage patterns from peptide communities
Larazotide side effects
Reported adverse effects and safety considerations
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.